Articles:

XJ Yu, C Waeber, N Castanon, K Scearce, R Hen, JE Macor, J Chauveau, MA Moskowitz, and J] Chaveau J [corrected to Chauveau

5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl - tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors [published erratum appears in Mol Pharmacol 1996 Oct;50(4):1055]
Mol Pharmacol 1996 49: 761-765. [Abstract] [PDF]  

JM Barret, P Calsou, G Laurent, and B Salles

DNA repair activity in protein extracts of fresh human malignant lymphoid cells
Mol Pharmacol 1996 49: 766-771. [Abstract] [PDF]  

A Skladanowski, SY Plisov, J Konopa, and AK Larsen

Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors
Mol Pharmacol 1996 49: 772-780. [Abstract] [PDF]  

EB Haddad, J Rousell, JC Mak, and PJ Barnes

Transforming growth factor-beta 1 induces transcriptional down- regulation of m2 muscarinic receptor gene expression
Mol Pharmacol 1996 49: 781-787. [Abstract] [PDF]  

AJ Freemerman, AJ Turner, MJ Birrer, E Szabo, K Valerie, and S Grant

Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C
Mol Pharmacol 1996 49: 788-795. [Abstract] [PDF]  

TJ Carlson and RE Billings

Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450
Mol Pharmacol 1996 49: 796-801. [Abstract] [PDF]  

D Wu and AI Cederbaum

Expression of cytochrome P4502E1 in rat fetal hepatocyte culture
Mol Pharmacol 1996 49: 802-807. [Abstract] [PDF]  

D Macdonald, SC Silberman, JA 3rd Lowe, SE Drozda, SE Leeman, and ND Boyd

Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist
Mol Pharmacol 1996 49: 808-813. [Abstract] [PDF]  

DN Rao, MX Yang, JM Lasker, and AI Cederbaum

1-Hydroxyethyl radical formation during NADPH- and NADH-dependent oxidation of ethanol by human liver microsomes
Mol Pharmacol 1996 49: 814-821. [Abstract] [PDF]  

F Impagnatiello, C Pesold, P Longone, H Caruncho, JM Fritschy, E Costa, and A Guidotti

Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam
Mol Pharmacol 1996 49: 822-831. [Abstract] [PDF]  

YH Ling, AK el-Naggar, W Priebe, and R Perez-Soler

Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells
Mol Pharmacol 1996 49: 832-841. [Abstract] [PDF]  

HM Beere, CM Chresta, and JA Hickman

Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells
Mol Pharmacol 1996 49: 842-851. [Abstract] [PDF]  

MB Ghasemzadeh, S Sharma, DJ Surmeier, JH Eberwine, and MF Chesselet

Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study
Mol Pharmacol 1996 49: 852-859. [Abstract] [PDF]  

M Goto, K Yamada, K Katayama, and I Tanaka

Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor- kappa B
Mol Pharmacol 1996 49: 860-873. [Abstract] [PDF]  

PV Nerurkar, HA Schut, LM Anderson, CW Riggs, LW Fornwald, CD Davis, EG Snyderwine, SS Thorgeirsson, WW Weber, JM Rice, and GN Levy

Ahr locus phenotype in congenic mice influences hepatic and pulmonary DNA adduct levels of 2-amino-3-methylimidazo[4,5-f]quinoline in the absence of cytochrome P450 induction
Mol Pharmacol 1996 49: 874-881. [Abstract] [PDF]  

J Balzarini, H Pelemans, MJ Perez-Perez, A San-Felix, MJ Camarasa, E De Clercq, and A Karlsson

Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine
Mol Pharmacol 1996 49: 882-890. [Abstract] [PDF]  

ZH Song and TI Bonner

A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2
Mol Pharmacol 1996 49: 891-896. [Abstract] [PDF]  

JE Hawkinson, JA Drewe, CL Kimbrough, JS Chen, DJ Hogenkamp, NC Lan, KW Gee, KZ Shen, ER Whittemore, and RM Woodward

3 alpha-Hydroxy-3 beta-trifluoromethyl-5 alpha-pregnan-20-one (Co 2- 1970): a partial agonist at the neuroactive steroid site of the gamma- aminobutyric acidA receptor
Mol Pharmacol 1996 49: 897-906. [Abstract] [PDF]  

JM Thomas and BB Hoffman

Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform
Mol Pharmacol 1996 49: 907-914. [Abstract] [PDF]  

A Lorenzen, L Guerra, H Vogt, and U Schwabe

Interaction of full and partial agonists of the A1 adenosine receptor with receptor/G protein complexes in rat brain membranes
Mol Pharmacol 1996 49: 915-926. [Abstract] [PDF]  

KE McCrea and SJ Hill

Comparison of duration of agonist action at beta 1- and beta 2- adrenoceptors in C6 glioma cells: evidence that the long duration of action of salmeterol is specific to the beta 2-adrenoceptor
Mol Pharmacol 1996 49: 927-937. [Abstract] [PDF]  

GH Fletcher and JH Steinbach

Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors
Mol Pharmacol 1996 49: 938-947. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.